Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma

Overview of attention for article published in OncoTargets and therapy, January 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,825 followers.

documentación: "Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine"https://t.co/NhbvQCLLPE

This is important: "This study was partially funded by the Spanish Ministry of Economy and Competitiveness" https://t.co/m43QVR3pb5 #cancer

RT @incliva_iis: #Publicaciones El Dr. Francisco Dasí (https://t.co/leNO9IDcZP) ha publicado en la revista Onco Targets Ther https://t.co/u…